Skip to main content

Table 1 Patient characteristics at the day of enrollment.

From: Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C

 

Adjunctive APC-treatmenta

No adjunctive APC-treatmentb

Age, years

47 (40.0/66.5)c

64.5 (58.25/74.25)c

Number of patients

5

4

Sex distribution, male

60%

75%

Scores, points

  

APACHE II

25 (23.5/28.5)c

25 (19.75/34.75)c

SAPS

50 (49/59.5)c

62 (47.75/67.75)c

ISTH

3 (3/3)c

3 (3/3)c

SOFA

9 (8/11.5)c

11 (9.25/12.75)c

Pathogen

  

Gram-positive

3

4

Gram-negative

2

0

Focus

  

Lung

2

2

Abdomen

2

3

Urogenital

2

1

Various

1

0

Laboratory findings

  

Procalcitonin, ng/mL

20.57 (4.79/33.09)c

1.18 (0.37/29.66)c

Leukocytes, Gpt/L

18.5 (4.4/37.25)c

27.2 (4.25/40.75)c

Outcome

  

Length of stay at ICU, days

8 (7/24)c

13.5 (4/40.25)c

Length of stay at hospital, days

34 (22/60)c

19 (4.25/65.25)c

Mortality rate, %

0

50

  1. aPatients who received APC (n = 5).
  2. bPatients with placebo (n = 4).
  3. cData given as median (25th/75th percentile).